The violet module, which closely tracked the abundance of clone 2, was significantly enriched with genes from reported astrocytoma expression programs, as well as TNFalpha signaling and extracellular matrix components. The gene discussed is TNF; the disease is astrocytoma (excluding glioblastoma).